| abstract |
The present disclosure relates to an oligopeptide. The oligopeptide includes an amino acid sequence having at least 50% identity with at least one of full-length amino acid sequences of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3 or SEQ ID NO. 4. The present disclosure also relates to a testing kit including the oligopeptide and a medical composition including the oligopeptide. Therefore, it has application potentials in related arts. |